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The thermogenic effect of a high energy supplement was examined in ten healthy and physically active 
female subjects that underwent two testing sessions administered in a randomized and double-blind fashion. 
The subjects reported to the Human Performance Laboratory after at least a 3-hour post-absorptive state 
and were provided either 120 ml of the supplement (SUP), or 120 ml of a placebo (PL). Following ingestion 
the subjects rested in a semi-recumbent position for 3 hours. The area under the curve analysis revealed no 
difference in oxygen consumption between SUP and PL for the 3 hours study period. No difference in en-
ergy expenditure was seen between SUP (.92±.16 kcal·min-1) and PL (.89±.17 kcal·min-1). A signifi cant dif-
ference in the utilization of stored fat as an energy source was seen between the groups during the 3 hours 
study (.42±.18 kcal·min-1 and .24±.10 kcal·min-1 in SUP and PL, respectively). These differences were seen 
in the fi rst (.35 ±.19 kcal·min-1 and .20±.13 kcal·min-1 in SUP and PL, respectively) and second hour (.46±.21 
kcal·min-1 and .24±.11 kcal·min-1 in SUP and PL, respectively), but not in the third hour (.47±.25 kcal·min-1 
and .33±.20 kcal·min-1 in SUP and PL, respectively). No differences in heart rate, blood pressure or mood 
were seen between the groups. The results indicate that although acute ingestion of this supplement does not 
increase energy expenditure, it does appear to stimulate a signifi cant increase in fat utilization. 
Key words: females, energy expenditure, oxygen consumption, respiratory quotient, heart rate, blood 
pressure, mood state
Introduction
Recent research has indicated that high energy 
drinks are the most popular supplement besides 
vitamins in the American adolescent and young 
adult population (Bell, Dorsch, McCreary, & Hov-
ey, 2004; Dodge & Jaccard, 2006; Hoffman et al., 
2008). The desire to reduce or control body fat ap-
pears to be the primary reason for the use of these 
supplements (Bell et al., 2004; Dodge & Jaccard, 
2006; Hoffman et al., 2008). Thermogenic supple-
ments can accomplish these goals by increasing 
both energy expenditure and the rate of fat oxi-
dation. Often, caffeine is the primary ingredient 
in these supplements. However, despite research 
demonstrating that caffeine is effective in enhanc-
ing lipolysis and fat oxidation (Acheson, Zahors-
ka-Markiewicz, Pittet, Anantharaman, & Jéquier, 
1980; Dulloo, Geisler, Horton, Collins, & Miller, 
1989), its effects are magnifi ed when it is combined 
with other anorexic agents (Haller, Jacob, & Be-
nowitz, 2004; Hoffman et al., 2006). Thus, caffeine 
is often combined with one or more of these agents 
to enhance the thermogenic effect.
Many thermogenic supplements contain am-
phetamine-like compounds such as ephedra or 
synephrine that increase energy metabolism by 
stimulating adrenergic receptors resulting in en-
hanced fat breakdown, appetite suppression and en-
ergy expenditure (Hoffman & Stout, 2008). How-
ever, the side effects associated with these stimu-
lants such as elevations in blood pressure and heart 
rate may cause uneasiness on the part of some us-
ers, and potentially can result in untoward events 
in individuals with underlying cardiovascular dis-
ease. As a result, some nutritional companies have 
begun to market weight loss supplements with in-
gredients that have more mild stimulatory effects 
and also focus more on fat metabolism and appe-
tite suppression. 
Additional ingredients in these weight loss sup-
plements may include herbal and botanical com-
pounds whose primary role is to increase fat oxi-
dation and possible mood enhancement. Some of 
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these products may include yohimbine, evodiamine, 
and hordenine, all of which have been shown to play 
a role in enhancing lipolysis and increasing ener-
gy expenditure (Barwell, Basma, Lafi , & Leake, 
1989; Galitzky et al., 1988; Kobayashi et al., 2001), 
while phenylethylamine, 5-hydroxytryptophan and 
St. Johns wort extract are compounds that are re-
ported to enhance mood (Bell & Goodrick, 2002, 
Grimsby et al., 1997; Popplewell, Coffey, Mont-
gomery, & Burton, 1983; Sabelli, Fink, Fawcett, & 
Tom, 1996; Singewald, Sinner, Hetzenauer, Sartori, 
& Murck, 2004). In consideration of the popular-
ity in the use of these high energy supplements, 
research is warranted concerning their effi cacy. 
Thus, the purpose of this study was to examine 
the acute effect of a multi-ingredient high energy 
supplement on resting oxygen uptake, respiratory 




Ten female subjects (age 20.4±.8yrs; height 
165.4±6.6 cm; body mass 58.3±7.7 kg; body fat 
20.1±4.9 %) underwent two testing sessions admin-
istered in a randomized and double-blind fashion. 
Following an explanation of all procedures, risks, 
and benefi ts associated with the experimental proto-
col, each subject gave her written informed consent 
to participate in this study. The Institutional Re-
view Board of the College of New Jersey approved 
the research protocol. Subjects who were pregnant, 
smokers or taking regular medication except birth 
control pills were excluded from the study. Sub-
jects with any known metabolic or cardiovascular 
disease, or psychiatric disorder were also excluded. 
Subjects were also required to have been free of any 
nutritional supplements or ergogenic aids for the 6 
weeks preceding the study, and were asked to re-
frain from taking any additional supplement dur-
ing the duration of the study. 
Study Design
The study followed a randomized double-blind, 
crossover design. The subjects reported to the Hu-
man Performance Laboratory on two separate days. 
Each testing session was separated by an average of 
8 days (8.2±5.2 days). The subjects were instructed 
to refrain from consuming any caffeine products on 
the day of each testing session and from perform-
ing any strenuous physical activity for the previous 
12 hours. In addition, the subjects were instructed 
to be at least 3 hours post-absorptive state prior to 
each trial. Following a 30-min resting period the 
subjects were randomly provided either the supple-
ment (SUP) or the placebo (PL). On the subject’s 
second visit to the laboratory they were provided 
with the opposite treatment. 
Metabolic Measures
Immediately following supplement ingestion 
the subjects were fi tted with a Medgraphics pre-
Vent™ pneumotach (Medical Graphics Corpora-
tion, St. Paul, MN) to measure oxygen consump-
tion (VO2) and respiratory quotient (RQ) through 
open-circuit spirometry using a metabolic measure-
ment cart (CPX Ultima™ series, Medical Graph-
ics Corporation, St. Paul, MN ) using breath-by-
breath analysis. Machine calibration was performed 
prior to each session. Measures were obtained one 
minute following supplement or placebo consump-
tion, every 5 minutes for the fi rst 30 minutes, and 
every 10 minutes thereafter until 180 minutes post 
consumption. Heart rate (HR) was also measured at 
these time points using a wireless HR monitor (Pac-
er, Polar CIC, Inc., Port Washington, NY), which 
updated HR display every 5 seconds. Blood pres-
sure (BP) was measured using a sphygmomanom-
eter and ausculatory method at 15 and 30 minutes 
post ingestion, and then every 30 minutes until the 
data collection concluded. 
Questionnaires
The profi le of mood states (POMS) was admin-
istered seven times during each testing session. The 
initial POMS administration was given as the sub-
ject reported to the Human Laboratory, and every 
half hour for the three hour period following supple-
ment ingestion. All questionnaires were performed 
under controlled conditions (a quiet room solely 
with the investigator) and the same researcher per-
formed all test administrations. 
The POMS consisted of 65 words or phrases in 
a Likert format questionnaire which provides meas-
ures of specifi c mood states. It provides measures of 
tension, depression, anger, vigor, fatigue and con-
fusion. A total mood score was computed by sub-
tracting vigor from the sum of the fi ve other nega-
tive measures and adding 100 to avoid a negative 
result. McNair, Lorr, and Droppleman (1971) have 
reported internal consistency of measures ranging 
between .85 to .95 and test-retest reliability esti-
mates ranging between .65 and .74. These lower 
coeffi cients of stability are thought to be indicative 
of transient and fl uctuating characteristics of mood 
states. During all test administrations the partici-
pants were asked to describe their feelings as to 
how they were feeling at that moment.
Supplement
On each visit the subjects consumed 120 ml 
of a ready-to-drink supplement (SUP) or placebo 
(PL). The supplement used is marketed as Redline 
Princess® (Vital Pharmaceuticals, Davie, FL) and 
contains caffeine, beta-alanine, vitamin C, and the 
following herbal and botanical compounds; Beta 
phenylethylene, hordenine HCL, Evodiamine, N-
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methyl tyramine, 5-hydroxytryptophan, potassium 
citrate, vinpocetine, yohimbine HCL, and St. Johns 
wort extract. The placebo was similar in appearance 
and taste to Redline Princess®, but contained only 
an inert substance. 
Statistical Analyses
The area under the curve (AUC) for VO2 
was calculated by using a standard trapezoidal 
technique. RQ, HR, BP and POMS were averaged 
over each hour and the entire 180-minute period. 
Statistical analysis of the data was accomplished 
using a repeated measures analysis of variance. In 
the event of a signifi cant F-ratio, LSD post-hoc tests 
were used for pair-wise comparisons. AUC analysis 
and 180-minute comparisons were analyzed using 
dependent t-tests. A criterion alpha level of p≤.05 
was used to determine statistical signifi cance. All 
data are reported as mean±SD. 
Results
The area under the curve analysis revealed 
no signifi cant differences in VO2 between SUP 
and PL for the three-hour study period (Figure 1). 
In addition, no signifi cant difference in energy 
expenditure was seen between SUP (.92±.16 
kcal·min-1) and PL (.89±.17 kcal·min-1) during the 
entire three-hour study (Figure 2). A signifi cant 
difference was seen between the two groups in 
the average RQ for the three-hour study period 
(Figure 3). Although no change was seen in caloric 
expenditure during the three-hour study protocol, 
there was a signifi cant difference observed in the 
utilization of fat as an energy source (Figure 4). 
Differences in the utiliza-tion of fat were seen in 
the fi rst (.35±.19 kcal·min-1 and .20±.13 kcal·min-
1 in SUP and PL, respectively) and second hour 
(.46±.21 kcal·min-1 and .24±.11 kcal·min-1 in SUP 
and PL, respectively), but not seen in the third hour 
(.47±.25 kcal·min-1 and .33±.20 kcal·min-1 in SUP 
and PL, respectively).
Figure 1. Under the curve analysis for 3-hour post-exercise 
oxygen consumption following supplement ingestion. Data 
are reported as mean±SD.
Figure 3. Average 3-hour respiratory quotient (RQ). 
* = significant difference (p<.05) between the supplement 
and placebo. Data are reported as mean±SD.
Figure 4. Average 3-hour fat utilization. * = significant 
difference (p<.05) between the supplement and placebo. 
Data are reported as mean±SD.
Figure 2. Average 3-hour energy expenditure. Data are 
reported as mean±SD.
The average hourly cardiovascular response to 
the study protocol is seen in Table 1. No signifi -
cant differences in the average hourly heart rate, or 
systolic and diastolic blood pressure between the 
groups were seen during the 3-hour study. Com-
parisons between groups in the average profi le of 
mood states scores can be observed in Figure 5. 
Analysis of mood states showed no differences in 
tension, depression, anger, vigour, fatigue and con-
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Tension Depression Anger Vigour Fatigue Confusion
Table 1. Average hourly cardiovascular measures
Variable Hour 1 Hour 2 Hour 3
Heart rate (b·min-1)
Supplement 66.1±7.2 67.5±8.7 67.1±13.9
Placebo 73.4±10.7 69.6±9.9 67.4±10.5
Systolic blood 
pressure (mmHg)
Supplement 102.6±3.9 103.0±4.6 102.6±3.7
Placebo 104.0±7.1 103.6±5.9 103.9±7.1
Diastolic blood 
pressure (mmHg)
Supplement 73.9±5.5 72.4±5.3 73.1±5.7
Placebo 73.4±5.0 73.8±4.1 72.0±5.3
Discussion
The results of this study indicate that a high en-
ergy supplement containing caffeine, beta-alanine, 
vitamin C, and the following herbal and botanical 
compounds; Beta phenylethylene, hordenine HCL, 
Evodiamine, N-methyl tyramine, 5-hydroxytryp-
tophan, potassium citrate, vinpocetine, yohimbine 
HCL, and St. Johns wort extract is effective in sig-
nifi cantly increasing fat utilization, but does not in-
crease acute energy expenditure in young, healthy 
females. Ingestion of this supplement did not result 
in any change to heart rate or blood pressure indi-
cating that this supplement may not pose a signifi -
cant cardiovascular health risk in apparently healthy 
subjects. In addition, acute ingestion of this supple-
ment did not alter mood in these subjects.
Caffeine has been shown to be effective in in-
creasing lipolysis and fat oxidation (Acheson et al., 
1980; Dulloo et al., 1989). However, its ability to 
increase energy expenditure may become more pro-
nounced only when it is combined with compounds 
that stimulate adrenergic receptors such as ephe-
dra or synephrine (Hoffman et al., 2006; Green-
way, de Jonge, Blanchard, Frisard, & Smith, 2004; 
Roberts, de Jonge-Levitan, Parker, & Greenway, 
2005; Vukovich, Schoorman, Heilman, Jacob III, & 
Benowitz, 2005). Considering that the supplement 
examined in this study con-
tained compounds with only 
very mild stimulatory action, 
it is not surprising that energy 
expenditures during SUP was 
not signifi cantly different com-
pared to the placebo ingestion. 
Similarly, it also explains the 
lack of any change in heart rate 
and blood pressure response to 
the supplement.
The signifi cant increase 
in the utilization of stored fat 
as the primary energy source 
during supplement adminis-
tration in this study is likely 
related to the combination of 
yohimbine, evodiamine, and 
hordenine. Yohimbine is a se-
lective α-adrenoceptor antago-
nist that has been reported to 
be effective in enhancing lip-
id metabolism (Galitzky et al., 
1988; Lafontan, Berlan, Galitz-
ky, & Montastruc, 1992). Evo-
diamine is a major alkaloidal 
from evodia fruits that has been 
shown to stimulate vanilloid re-
ceptor activities comparable to 
capsaicin (compound found in 
hot peppers) (Kobayashi et al., 
2001). Limited research on evo-
diamine has shown that it can enhance lipolysis by 
raising core body temperature (Kobayashi, 2003). 
However, we can only speculate on that since core 
body temperature was not measured during this 
study. Hordenine is also an alkaloid that occurs 
naturally in grains, sprouting barley and certain 
grasses, but it is also found in small quantities in 
citrus aurantium (Slezak, Francis, Anastos, & Bar-
nett, 2007). Citrus aurantium, a fruit commonly 
known as “bitter orange”, is used in Asian herbal 
medicines to treat digestive problems (Fugh-Ber-
man & Myers, 2004). It is also a mild stimulant that 
contributes to appetite suppression and enhances 
metabolic rate (Fugh-Berman & Myers, 2004). The 
combination of these three compounds in this sup-
plement appears to be effective in enhancing fat 
oxidation for the three hour period following sup-
plement ingestion, however the stimulatory effects 
from these compounds did not cause any increase 
in energy expenditure or change in cardiovascular 
measures.
The addition of phenylethylamine, 5-hydrox-
ytryptophan and St. Johns wort extract as ingredi-
ents was intended to enhance the mood of subjects 
using this supplement. However, the results of this 
study indicate that acute ingestion of these ingre-
dients failed to enhance mood signifi cantly. Both 
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phenylethylamine and 5-hydroxytryptophan are 
thought to enhance mood by stimulating dopamine 
release (Nakamura, Ishii, & Nakahara, 1998) and 
enhancing serotonin production (Rahman et al., 
1982), respectively. St. Johns wort extract appears 
to act by reducing β-adrengergic receptor bind-
ing (Simbrey, Winterhoff, & Butterweck, 2003). 
However, an acute ingestion of these ingredients 
may not be suffi cient to stimulate signifi cant mood 
changes. Simbrey and colleagues (2003) reported 
that even after two weeks of St. Johns wort extract 
treatment no signifi cant changes in β-adrengergic 
receptor binding was seen, but only after 8-weeks 
of treatment was signifi cant changes realized. An 
acute effect on mood from phenylethylamine inges-
tion has been reported that is thought to be infl u-
enced by its modulating effect on catecholamine re-
lease (Popplewell et al., 1983). It is possible that the 
phenylethylamine concentration in this supplement 
(exact content not released by the manufacturer) 
was insuffi cient to cause any acute mood changes, 
and that a prolonged duration of supplement intake 
may be needed to stimulate mood changes related 
to 5-hydroxytryptophan and St. Johns wort extract 
treatment. Interestingly, phenylethylamine has also 
been shown to reduce appetite (Dourish & Boulton, 
1981), and to stimulate lipolysis through its ability 
to stimulate catecholamine release and delay the re-
uptake of these neurotransmitters (Paterson, Juorio, 
& Boulton, 1990). Although this present study in-
dicated that phenylethylamine did not affect mood, 
it may have contributed to the greater reliance on 
fat as an energy source. 
The role that the additional ingredients in the 
supplement (e.g beta-alanine, tyramine, and vin-
pocetine) may have had is not clear. Beta-alanine is 
a non-proteogenic amino acid that can enhance the 
buffering capacity of muscle by increasing muscle 
carnosine concentrations (Dunnett & Harris, 1999). 
Its role as a high energy supplement though is ques-
tionable, considering that it has no known acute ef-
fect on metabolic rate or stimulation of adrenergic 
receptors (Hoffman & Stout, 2008). Tyramine is a 
monoamine compound that is derived from the ami-
no acid tyrosine. It is an indirect sympathomimetic, 
meaning that it does not directly activate adrener-
gic receptors, but acts as a substrate for adrenergic 
uptake systems and monoamine oxidase prolonging 
the actions of adrenergic transmitters (Youdim & 
Weinstock, 2004). It has been used therapeutically 
to fi ght depression (Youdim & Weinstock, 2004). 
Its function in a high energy supplement may be 
to increase the sympathetic response. However, 
based upon the results of this study, its effective-
ness in combination with the other ingredients used 
in this study was unable to be demonstrated. Vin-
pocetine is a derivative of vinacamine; a purifi ed 
extract of Vinca Minor L (Periwinkle plant). It has 
been used as a cerebral vasodilator for enhancing 
mental alertness and memory (Kidd, 1999), and 
has also been shown to have antioxidant properties 
(Santos, Duarte, Moreira, & Oliveiera, 2000). This 
study though did not directly address the ability of 
vinpocetine to effect alertness or memory. Further 
research will need to determine whether the con-
centration of vinpocetine used in this high energy 
supplement is an effective agent in enhancing alert-
ness and cognitive function.
In conclusion, the results of this study indicate 
that acute ingestion of Redline Princess® does not 
increase energy expenditure in young, healthy fe-
males. However, this high energy supplement does 
appear to enhance fat utilization without stimulat-
ing any increases in heart rate or blood pressure. 
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Cilj ovog istraživanja bio je ispitati akutne efekte 
napitka za poticanje energetske potrošnje na pri-
mitak kisika u mirovanju (VO2), respiracijski kvoci-
jent (RQ), potrošnju kalorija (kcal), frekvenciju srca 
(HR) i krvni tlak (BP) kod zdravih i fizički aktivnih 
ispitanika ženskog spola. 
Metode
Deset žena (u dobi od 20,4±,8 godina; visokih 
165,4±6,6 cm; tjelesne mase 58,3±7,7 kg; s posto-
tkom tjelesne masti od 20,1±4,9 %) testirano je dva 
puta metodom slučajnog i dvosmjerno anonimnog 
odabira. U oba mjerenja, provedena u Laboratory 
for Human Performance, ispitanice koje nisu ništa 
konzumirale prethodna 3 sata, uzimale su ili 120 
ml suplementa (SUP) ili 120 ml placeba (PL). Ispi-
tanice su nakon uzimanja supstancije 3 sata mi-
rovale u poluležećem položaju. VO2 i frekvencija 
srca bilježeni su svakih 5 minuta tijekom prvih pola 
sata te svakih 10 minuta tijekom sljedećih 150 mi-
nuta. Krvni tlak je mjeren svakih 15 minuta tijekom 
prvih pola sata te svakih 30 minuta kroz preostalo 
vrijeme testiranja. Profil raspoloženja utvrđivao se 
svakih 30 minuta. Analizom površine ispod krivul-
je (AUC) izračunat je VO2, dok su se prosjek za tri 
sata i prosjek svakog pojedinačnog sata utvrđivali 
za respiracijski kvocijent (RQ), potrošnju ugljikohi-
drata u kcal, potrošnju masti u kcal, ukupnu potro-
šnju u kcal, frekvenciju srca i krvni tlak. 
Rezultati i rasprava
Analiza površine ispod krivulje pokazala je da 
nema statistički značajnih razlika u primitku kisika 
(VO2) između SUP i PL skupina ispitanica za vrije-
me od tri sata u kojem je testiranje provedeno (sli-
ka 1). Isto tako nije pronađena statistički značaj-
na razlika u potrošnji energije između grupa SUP 
(0,92±0,16 kcal/min) i PL (0,89±0,17 kcal/min) tije-
kom testiranja (slika 2). Značajna razlika zabilježe-
na je između grupa u prosječnom RQ za vrijeme te-
stiranja (slika 3). Iako nije zabilježena nikakva prom-
jena u kalorijskoj potrošnji, značajne razlike zabilje-
žene su u potrošnji masti kao izvoru energije (slika 
4). Navedene razlike zabilježene su tijekom prvog 
(0,35±0,19 kcal/min u grupi SUP i 0,20±0,13 kcal/
min u grupi PL) i drugog sata mjerenja (0,46±0,21 
kcal/min u grupi SUP i 0,24±0,11 kcal/min u gru-
pi PL), ali nisu zabilježene značajne razlike izme-
đu grupa tijekom trećeg sata mjerenja (0,47±0,25 
kcal/min u grupi SUP i 0,33±0,20 kcal/min u grupi 
PL). Tijekom trosatnog protokola mjerenja nisu za-
bilježene ni statistički značajne razlike u frekven-
ciji srca niti u sistoličkom ni dijastoličkom krvnom 
tlaku (tablica 1). Analiza stanja raspoloženja (slika 
5) nije pokazala razlike između grupa u napetosti, 
depresiji, ljutnji, žestini, umoru i zbunjenosti tijekom 
trosatnog testiranja.
Rezultati ovog istraživanja pokazuju da uziman-
je napitka Redline Princess® ne povećava potrošn-
ju energije u mladih i zdravih žena, ali da značajno 
stimulira potrošnju masti. Nadalje, uzimanje ovog 
suplementa ne stimulira i ne povisuje frekvenciju 
srca kao ni krvni tlak. 
TERMOGENI UČINCI STIMULACIJSKOG NAPITKA, 
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